학술논문

An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
Document Type
Article
Source
In: Science Translational Medicine. (Science Translational Medicine, 13 March 2024, 16(738))
Subject
Language
English
ISSN
19466242
19466234